In conclusion, our preliminary study indicated that IL-6 (-174 G/C and -597 G/A) polymorphisms may play a role in HCV susceptibility in HD patients, and IL-6 -174 G/C polymorphisms may play a role in the regulation of hepcidin and iron levels in HD patients. The gene discussed is HAMP; the disease is Huntington disease.